Strategy Phase III Intergroup Study for Chemotherapy of the Metastatic or Locally Advanced Cancers of the Stomach
To compare the effectiveness of two different sequences of polychemotherapy among carrying
patients of a adenocarcinoma of the stomach or cardia locally advanced or metastatic.
Interventional
Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Treatment
Time until therapeutic failure : to make pass TET from 15 weeks with ECC in first line to 20 weeks with FOLFIRI in first line
20 weeks
Yes
Rosine GUIMBAUD, MD
Principal Investigator
CHU TOULOUSE
France: Afssaps - Agence française de sécurité sanitaire des produits de santé (Saint-Denis)
0305603
NCT00374036
June 2005
December 2009
Name | Location |
---|